Drug recall · August 17, 2022
Difluprednate Ophthalmic Emulsion 0.05% recall
Why: Lack of Assurance of Sterility: Complaints received of defective container closure.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 69097-341-35.
- Lots / codes
Lot # DEG3LC2, Exp 05/2023
- Quantity
- 7,992 bottles
- Company
- Cipla, Warren, NJ
- Distribution
- Nationwide in the USA
- Initiated
- August 2, 2022 · Voluntary: Firm initiated
- Classified
- August 5, 2022
- Reported
- August 17, 2022
- Ended
- November 27, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Difluprednate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.